Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(25%)
Results Posted
50%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph early_phase_1
3
25%
Ph not_applicable
7
58%
Ph phase_2
2
17%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
3(25.0%)
Phase 2Efficacy & side effects
2(16.7%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Recruiting3
unknown1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 13 (25.0%)
Phase 22 (16.7%)
N/A7 (58.3%)

Trials by Status

unknown18%
withdrawn18%
completed650%
recruiting325%
terminated18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
RADIATION
Total Trials
12